AbCellera Biologics (ABCL) Income towards Parent Company (2020 - 2026)
AbCellera Biologics (ABCL) posted Income towards Parent Company of -$55.43 million for Q2 2026, compared with -$34.73 million a year earlier.
Powered by 
Analysis
AbCellera Biologics (ABCL) Income towards Parent Company (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at AbCellera Biologics was -$164.66 million; for FY2025, it was -$146.41 million.
- In prior years, AbCellera Biologics' Income towards Parent Company was -$162.86 million in FY2024, -$146.4 million in FY2023, $158.52 million in FY2022 (+3.3%) and $153.46 million in FY2021 (+29.1%).
- Quarterly Income towards Parent Company has run from a low of -$57.12 million in Q3 2025 to a high of $168.57 million in Q1 2022 over five years.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was -$43.17 million (Q1 2026), -$8.95 million (Q4 2025) and -$57.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.43 Mn |
| Mar 31, 2026 | -43.17 Mn |
| Dec 31, 2025 | -8.95 Mn |
| Sep 30, 2025 | -57.12 Mn |
| Jun 30, 2025 | -34.73 Mn |
| Mar 31, 2025 | -45.62 Mn |
| Dec 31, 2024 | -34.21 Mn |
| Sep 30, 2024 | -51.11 Mn |
| Jun 30, 2024 | -36.93 Mn |
| Mar 31, 2024 | -40.61 Mn |
| Dec 31, 2023 | -47.15 Mn |
| Sep 30, 2023 | -28.61 Mn |
| Jun 30, 2023 | -30.53 Mn |
| Mar 31, 2023 | -40.11 Mn |
| Dec 31, 2022 | -29.89 Mn |
| Sep 30, 2022 | 26.62 Mn |
| Jun 30, 2022 | -6.79 Mn |
| Mar 31, 2022 | 168.57 Mn |
| Dec 31, 2021 | 59.95 Mn |
| Sep 30, 2021 | -21.38 Mn |
API Access
AbCellera Biologics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();